Literature DB >> 2713210

Healthy volunteer studies in Great Britain: the results of a survey into 12 months activity in this field.

M Orme1, J Harry, P Routledge, S Hobson.   

Abstract

1. A survey has been conducted amongst 459 members of the Clinical Section of the British Pharmacological Society to ascertain facts about the administration of drugs to healthy volunteers over the period October 1986 to September 1987. 2. A response rate of 87.1% was obtained with 114 individuals being involved in healthy volunteer studies. After exclusion of duplicate returns from the same unit 98 questionnaires were analysed. 3. Drugs were given in the year under review to 8163 healthy volunteers for research purposes. Minor adverse effects were reported in 565 (6.9%), moderately severe adverse effects in 45 (0.55%) and potentially life threatening adverse effects in 3 (0.04%). No lasting sequelae were reported. 4. Drugs were given to 7607 healthy student volunteers as part of class teaching practicals. Minor adverse effects were reported in 6.0% of student exposures but no moderately severe or life threatening adverse effects were reported. 5. The risk involved in healthy volunteer studies is very small indeed but some suggestions are made as a result of the questionnaire to improve further the safety of these studies.

Mesh:

Year:  1989        PMID: 2713210      PMCID: PMC1379771          DOI: 10.1111/j.1365-2125.1989.tb05342.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Research on healthy volunteers--a report of the Royal College of Physicians.

Authors:  J D Harry
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

2.  Medical research on normal volunteers.

Authors:  J M Royle; E S Snell
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

3.  Adverse nondrug reactions.

Authors:  M M Reidenberg; D T Lowenthal
Journal:  N Engl J Med       Date:  1968-09-26       Impact factor: 91.245

4.  Recent experience of ethics committee review of a multicentre research project.

Authors:  J J Ashford
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

5.  A survey of the first year of operation of the new procedure affecting the conduct of clinical trials in the United Kingdom.

Authors:  C J Speirs; J P Griffin
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

  5 in total
  9 in total

1.  The prevalence and incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research.

Authors:  S D Singh; A J Williams
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

2.  Adverse events in phase one studies: a study in 430 healthy volunteers.

Authors:  M Sibille; N Deigat; V Olagnier; D V Durand; R Levrat
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Ethics of volunteer research: the role of new EC guidelines.

Authors:  W G Haynes; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

4.  Payments to healthy volunteers--ethical problems.

Authors:  D W Vere
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

5.  Sensation seeking amongst healthy volunteers participating in phase I clinical trials.

Authors:  M Farré; X Lamas; J Camí
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

Review 6.  Risks of phase I research with healthy participants: A systematic review.

Authors:  Rebecca A Johnson; Annette Rid; Ezekiel Emanuel; David Wendler
Journal:  Clin Trials       Date:  2015-09-08       Impact factor: 2.486

7.  Impact of endoscopy-based research on quality of life in healthy volunteers.

Authors:  Alexander Link; Gerhard Treiber; Brigitte Peters; Thomas Wex; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

8.  Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies.

Authors:  Ezekiel J Emanuel; Gabriella Bedarida; Kristy Macci; Nicole B Gabler; Annette Rid; David Wendler
Journal:  BMJ       Date:  2015-06-26

Review 9.  Reviewing the role of healthy volunteer studies in drug development.

Authors:  Joyson J Karakunnel; Nam Bui; Latha Palaniappan; Keith T Schmidt; Kenneth W Mahaffey; Briggs Morrison; William D Figg; Shivaani Kummar
Journal:  J Transl Med       Date:  2018-12-04       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.